Reporting Analytics for Pharmaceutical Teams

It covers the structured preparation, analysis and presentation of pharmaceutical business and operational data so teams can monitor agreed KPIs, trends, exceptions and performance. Scope can include commercial, quality, manufacturing, supply-chain, clinical-operations and safety-operations reporting, subject to the data and controls available.

No. Standard reporting analytics is decision-support work. Regulatory submissions, medical assessment, case processing, signal management, validated safety-system operation and regulated sign-off remain with the responsible qualified functions unless a separately defined and appropriately controlled scope is agreed.

Typical users include commercial and market-access teams, quality and manufacturing operations, supply-chain teams, clinical-operations teams, finance and leadership, as well as safety operations that need non-clinical decision-support reporting around workload, timeliness or process status.

Depending on scope, inputs may include Excel or CSV files, SQL extracts, ERP exports, QMS or LIMS exports, CRM data, CTMS or EDC operational extracts, inventory and distribution data, complaint or deviation summaries, and existing dashboard datasets. Access is confirmed only after the source and sensitivity are reviewed.

These tools can be considered when they fit the client environment and agreed scope. The final tool choice depends on licensing, source connectivity, security controls, refresh requirements, handoff needs and the systems already approved by the client.

The project begins by agreeing KPI names, business definitions, source fields, filters, time windows, calculation rules, ownership and intended audience. This reduces definition drift and helps stakeholders understand what each reported number represents.

Checks can include row-count and total reconciliation, spot checks against source extracts, duplicate and missing-value checks, calculation review, filter testing, period comparison, refresh timestamp review and documented exceptions. Client subject-matter owners remain responsible for approving business meaning and regulated use.

Yes, where access, data structure and permissions allow it. Multi-source work may require data mapping, common keys, transformation rules, refresh logic and reconciliation steps. Complex APIs, data warehouses, validated environments or restricted systems may require custom scope.

Yes. Examples can include batch or release workflow status, deviations, CAPA ageing, complaint trends, right-first-time indicators, cycle times and other approved operational measures. Exact metrics are defined with the client and should not be interpreted as regulatory conclusions unless the responsible quality function approves that use.

Yes, for operational decision support such as site status, enrolment progress, query ageing, milestone tracking or other agreed study-management measures derived from approved extracts. Statistical analysis of trial outcomes, medical interpretation and regulated submission analyses require specialist scope outside a standard dashboard build.

It can support operational analytics around volumes, workflow queues, ageing, timeliness, reconciliation status or management reporting when appropriate data is supplied. It does not replace safety-database processing, medical review, causality assessment, signal evaluation or authority submission responsibilities.

The starting package is intended for a focused, meaningful reporting requirement: one dashboard or reporting pack, up to two prepared data sources, up to eight agreed KPIs, basic QA and reconciliation notes, one consolidated review round and handoff documentation. More complex data preparation or regulated controls require a larger scope.

Price changes with the number and condition of data sources, transformation effort, number of KPIs and pages, historical volume, required integrations, access restrictions, role-based views, refresh automation, validation or documentation expectations, stakeholder groups and ongoing reporting frequency.

A focused build can typically be planned for 5–7 working days after usable inputs and KPI definitions are available. Integrated builds may take 10–15 working days or longer. Timelines change when source access, data quality, stakeholder approval, system dependencies or regulated review steps are more complex.

Provide the reporting objective, intended audience, existing KPI definitions, representative source files or approved access, sample reports if available, expected refresh frequency, known business rules, data owners and the people who can validate calculations and approve the final output.

The preferred approach is data minimisation: use only what is necessary for the reporting scope and follow the client’s approved access, transfer, retention and confidentiality rules. Personal or sensitive data should not be sent in the initial enquiry. Any controlled-environment or regulated-data requirement should be identified before access is granted.

Rudrriv can hand over editable files and reporting documentation where applicable, explain refresh and maintenance steps, and separately scope ongoing updates, recurring report production or further integration work. The client retains ownership of internal approval and use decisions.